ACORN CAPITAL ADVISORS, LLC
CIK 0002054410
Annualised vol
13.875791%
Beta
0.108018
HHI
1177.080558
Top-10 weight
90.187862%
VaR 95%
1.257101%
VaR 99%
2.752626%
Max drawdown
24.603894%
Matched value
90.63815%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| CGON | ADDED | 1,131,500 | 1,130,501 | 0.09% | 80,393,115 |
| URGN | UNCHANGED | 1,673,420 | 1,673,420 | 0.0% | 61,581,856 |
| TRVI | UNCHANGED | 2,144,844 | 2,144,844 | 0.0% | 40,001,341 |
| CADL | UNCHANGED | 3,497,948 | 3,497,948 | 0.0% | 36,028,864 |
| PBYI | UNCHANGED | 4,131,299 | 4,131,299 | 0.0% | 33,504,835 |
| BCAX | REDUCED | 643,381 | 643,382 | 0.0% | 19,102,000 |
| KPTI | ADDED | 1,518,113 | 287,826 | 427.44% | 14,831,964 |
| OKUR | UNCHANGED | 2,839,674 | 2,839,674 | 0.0% | 12,948,913 |
| TARA | UNCHANGED | 1,752,115 | 1,752,115 | 0.0% | 6,693,079 |
| AURA | ADDED | 929,077 | 595,744 | 55.95% | 6,596,447 |
| LONA | UNCHANGED | 634,539 | 634,539 | 0.0% | 5,831,413 |
| VSTM | UNCHANGED | 1,469,153 | 1,469,153 | 0.0% | 5,612,164 |
| WHWK | UNCHANGED | 1,139,363 | 1,139,363 | 0.0% | 5,218,283 |
| QTTB | REDUCED | 216,171 | 315,052 | -31.39% | 2,754,019 |
| JSPR | ADDED | 1,438,159 | 1,411,492 | 1.89% | 604,027 |
| BCAB | REDUCED | 108,126 | 5,406,345 | -98.0% | 447,645 |
| XFOR | CLOSED OUT | 0 | 234,039 | -100.0% | 0 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| CGON | ADDED | CG ONCOLOGY INC | COM | 156944100 | 80,393,115 | 21.94 | 1131500.0 |
| URGN | UNCHANGED | UROGEN PHARMA LTD | COM | M96088105 | 61,581,856 | 16.8 | 1673420.0 |
| TRVI | UNCHANGED | TREVI THERAPEUTICS INC | COM | 89532M101 | 40,001,341 | 10.92 | 2144844.0 |
| CADL | UNCHANGED | CANDEL THERAPEUTICS INC | COM | 137404109 | 36,028,864 | 9.83 | 3497948.0 |
| PBYI | UNCHANGED | PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 33,504,835 | 9.14 | 4131299.0 |
| - | JADE BIOSCEINCES INC | COM NEW | 008064206 | 21,925,807 | 5.98 | 986760.0 | |
| BCAX | REDUCED | BICARA THERAPEUTICS | COM | 055477103 | 19,102,000 | 5.21 | 643381.0 |
| KPTI | ADDED | KARYOPHARM THERAPEUTICS INC | COMMON STOCK | 48576U205 | 14,831,964 | 4.05 | 1518113.0 |
| OKUR | UNCHANGED | ONKURE THERAPEUTICS INC | CLASS A COM | 68277Q105 | 12,948,913 | 3.53 | 2839674.0 |
| - | HELUS PHARMA INC. | COM STK | 23256X407 | 10,181,159 | 2.78 | 1540266.0 | |
| TARA | UNCHANGED | PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 6,693,079 | 1.83 | 1752115.0 |
| AURA | ADDED | AURA BIOSCIENCES INC | COM | 05153U107 | 6,596,447 | 1.8 | 929077.0 |
| LONA | UNCHANGED | LEONABIO, INC. | COMMON STOCK | 04746L203 | 5,831,413 | 1.59 | 634539.0 |
| VSTM | UNCHANGED | VERASTEM INC | COM | 92337C203 | 5,612,164 | 1.53 | 1469153.0 |
| WHWK | UNCHANGED | WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | 5,218,283 | 1.42 | 1139363.0 |
| QTTB | REDUCED | Q32 BIO INC. | COM | 746964105 | 2,754,019 | 0.75 | 216171.0 |
| - | EUGENE THERAPEUTICS | COM | 29286X101 | 2,199,275 | 0.6 | 1271257.0 | |
| JSPR | ADDED | JASPER THERAPEUTICS | COM | 471871202 | 604,027 | 0.16 | 1438159.0 |
| BCAB | REDUCED | BIOATLA INC | COM | 09077B104 | 447,645 | 0.12 | 108126.0 |
| - | VYNE THERAPEUTICS INC | COM | 92941V308 | 926 | 0.0 | 1425.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 366,457,132 | 20 | 13.875791 | 0.108018 | 24.603894 |
| 2026-03-31 | 2026-05-15 | 351,837,734 | 22 | 11.084187 | 0.090407 | 22.173227 |
| 2025-12-31 | 2026-02-17 | 295,133,293 | 21 | 10.487176 | 0.084921 | 20.078301 |
| 2025-09-30 | 2025-11-17 | 196,993,688 | 20 | 13.417935 | 0.109041 | 25.337583 |
| 2025-03-31 | 2025-05-19 | 149,945,296 | 22 | 12.223354 | 0.099545 | 23.749602 |
| 2024-12-31 | 2025-05-19 | 185,821,131 | 21 | 11.066391 | 0.089486 | 24.890812 |